The US Bankruptcy Court granted an order for the extension of the exclusivity periods for Musclepharm Corporation on May 10, 2023. As per the order, the debtor's exclusivity period to file its plan by 91 days i.e. up to July 14, 2023 and to solicit votes on its plan, have been extended up to September 12, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.92% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 33 | |
+210.80% | 6.73B | |
+9.53% | 1.17B | |
+2.00% | 982M | |
+41.91% | 872M | |
+21.91% | 799M | |
+6.82% | 675M | |
+1.72% | 664M | |
+72.63% | 654M | |
-.--% | 600M |
- Stock Market
- Equities
- MSLP.Q Stock
- News MusclePharm Corporation
- First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation